CardioCeption LLC, was formed in 2009 in Cincinnati, Ohio. The company is developing non-traumatic means of eliciting remote cardioprotection during MI, based upon novel discoveries by laboratories at the University of Cincinnati College of Medicine. CardioCeption is currently running translational trials in a large animal model to optimize this therapy. Based upon these results and ongoing clinical trials, the company will pursue R&D to expand the indications and commercialize the application of the technology.